Norton Thomas D - Regeneron Pharmaceuticals, Inc

基本信息

浏览量：4

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 38 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Checkpoint Inhibitor-Expressing Lentiviral Vaccine Suppresses Tumor Growth in Preclinical Cancer Models

Takuya Tada,Thomas D. Norton,Rebecca Leibowitz,Nathaniel R. Landau

JOURNAL FOR IMMUNOTHERAPY OF CANCER（2024）

引用0浏览0WOS引用

Thematic Analysis to Explore Patients’ Experiences with Long COVID-19: a Conceptual Model of Symptoms and Impacts on Daily Lives

Diana Rofail,Selin Somersan-Karakaya, Julia Y. Choi,Krystian Przydzial,Yuming Zhao,Mohamed Hussein,Thomas D. Norton,Anna J. Podolanczuk,Eleftherios Mylonakis,Gregory P. Geba

BMJ openno. 1 (2024): e076992-e076992

引用0浏览0WOS引用

Patient-Reported Outcomes in COVID-19 Treatment with Monoclonal Antibodies Reveal Benefits in Return to Usual Activities

Diana Rofail,Mohamed Hussein,Ulrike Naumann,Anna J. Podolanczuk,Thomas Norton,Shazia Ali,Vera Mastey,Cristina Ivanescu,Boaz Hirshberg,Gregory P. Geba

Infectious Diseases and Therapy（2024）

引用0浏览0WOS引用

Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS+IMD) in Pediatric Outpatients with COVID-19

Thomas D Norton, Mazhar Thakur,Samit Ganguly,Shazia Ali, Jesse Chao,Alpana Waldron, Jing Xiao,Kenneth C Turner, John D Davis,Susan C Irvin,Cynthia Pan, Dominique Atmodjo,Andrea T Hooper,Jennifer D Hamilton,Mohamed Hussein, Danise Subramaniam, Lilia Roque-Guerrero, Anita Kohli,Eleftherios Mylonakis, Gregory P Geba, Edward Cox,Ned Braunstein,Paula Dakin,Bari Kowal,Rafia Bhore,A Thomas DiCioccio, Diana Hughes,Gary A Herman, Trial Investigators

Journal of the Pediatric Infectious Diseases Society (2024)

引用0浏览0WOS引用

The Symptoms Evolution of Long COVID‑19 (SE-LC19): a New Patient-Reported Content Valid Instrument

Diana Rofail,Selin Somersan-Karakaya,Eleftherios Mylonakis, Julia Y. Choi,Krystian Przydzial, Sarah Marquis,Yuming Zhao,Mohamed Hussein,Thomas D. Norton,Anna J. Podolanczuk, Gregory P. Geba

JOURNAL OF PATIENT-REPORTED OUTCOMESno. 1 (2024)

引用0浏览0WOS引用

Assessing the Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS+IMD) in a Cohort of Pregnant Outpatients with COVID-19: Results from an Adaptive, Multicentre, Randomised, Double-Blind, Phase 1/2/3 Study

Thomas D Norton, Mazhar Thakur,Samit Ganguly,Shazia Ali, Jesse Chao, Alpana Waldron, Jing Xiao, Yogesh Patel,Kenneth C Turner, John D Davis,Susan C Irvin,Cynthia Pan, Dominique Atmodjo-Watkins,Andrea T Hooper,Jennifer D Hamilton, Danise Subramaniam,Joseph A Bocchini,Bari Kowal,A Thomas DiCioccio,Rafia Bhore, Gregory P Geba,Edward Cox,Ned Braunstein, Paula Dakin,Gary A Herman

BMJ open（2024）

引用0浏览0WOS引用

Casirivimab + Imdevimab Accelerates Symptom Resolution Linked to Improved COVID-19 Outcomes Across Susceptible Antibody and Risk Profiles

Dateng Li,Meng Xu,Andrea T. Hooper,Diana Rofail,Kusha A. Mohammadi,Yiziying Chen,Shazia Ali,Thomas Norton,David M. Weinreich,Bret J. Musser,Jennifer D. Hamilton,Gregory P. Geba

Scientific reportsno. 1 (2023)

引用0浏览0WOSNATURE引用

Evaluation of Common Gamma Chain Cytokine Signaling Blockade with REGN7257, an Interleukin 2 Receptor Gamma (IL2RG) Monoclonal Antibody, on Immune Cell Populations in Monkey and Human

Audrey Le Floch-Ramondou,Kirsten Nagashima,Kaitlyn Gayvert,Hao Pan,Chandrashekhar Korgaonkar, Hassan Shakil,Erica Ullman,Thomas Norton,Lorah Perlee,Andrew J. Murphy,Matthew Sleeman,Jamie Orengo

Blood（2022）

引用0浏览0引用

Directly Injected Lentiviral Vector–based T Cell Vaccine Protects Mice Against Acute and Chronic Viral Infection

Takuya Tada,Thomas D. Norton,Rebecca Leibowitz,Nathaniel R. Landau

JCI insight（2022）

引用4浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn